Literature DB >> 20889498

Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.

Max D Driscoll1, Kirsty J McLean, Colin Levy, Natalia Mast, Irina A Pikuleva, Pierre Lafite, Stephen E J Rigby, David Leys, Andrew W Munro.   

Abstract

The Mycobacterium tuberculosis cytochrome P450 enzyme CYP142 is encoded in a large gene cluster involved in metabolism of host cholesterol. CYP142 was expressed and purified as a soluble, low spin P450 hemoprotein. CYP142 binds tightly to cholesterol and its oxidized derivative cholest-4-en-3-one, with extensive shift of the heme iron to the high spin state. High affinity for azole antibiotics was demonstrated, highlighting their therapeutic potential. CYP142 catalyzes either 27-hydroxylation of cholesterol/cholest-4-en-3-one or generates 5-cholestenoic acid/cholest-4-en-3-one-27-oic acid from these substrates by successive sterol oxidations, with the catalytic outcome dependent on the redox partner system used. The CYP142 crystal structure was solved to 1.6 Å, revealing a similar active site organization to the cholesterol-metabolizing M. tuberculosis CYP125, but having a near-identical organization of distal pocket residues to the branched fatty acid oxidizing M. tuberculosis CYP124. The cholesterol oxidizing activity of CYP142 provides an explanation for previous findings that ΔCYP125 strains of Mycobacterium bovis and M. bovis BCG cannot grow on cholesterol, because these strains have a defective CYP142 gene. CYP142 is revealed as a cholesterol 27-oxidase with likely roles in host response modulation and cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889498      PMCID: PMC2992261          DOI: 10.1074/jbc.M110.164293

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 2.  25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles.

Authors:  Norman B Javitt
Journal:  J Lipid Res       Date:  2002-05       Impact factor: 5.922

3.  Characterization of 3-ketosteroid 9{alpha}-hydroxylase, a Rieske oxygenase in the cholesterol degradation pathway of Mycobacterium tuberculosis.

Authors:  Jenna K Capyk; Igor D'Angelo; Natalie C Strynadka; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 4.  New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.

Authors:  Emma C Rivers; Ricardo L Mancera
Journal:  Drug Discov Today       Date:  2008-10-18       Impact factor: 7.851

5.  Oxidation-reduction properties of several low potential iron-sulfur proteins and of methylviologen.

Authors:  N A Stombaugh; J E Sundquist; R H Burris; W H Orme-Johnson
Journal:  Biochemistry       Date:  1976-06-15       Impact factor: 3.162

6.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

7.  Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.

Authors:  Natalia Mast; Ryan Norcross; Ulla Andersson; Magang Shou; Kazuo Nakayama; Ingemar Bjorkhem; Irina A Pikuleva
Journal:  Biochemistry       Date:  2003-12-09       Impact factor: 3.162

Review 8.  The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.

Authors:  Kirsty J McLean; James Belcher; Max D Driscoll; Christine C Fernandez; Duyet Le Van; Soi Bui; Marina Golovanova; Andrew W Munro
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

9.  Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.

Authors:  Kirsty J McLean; Ashley J Warman; Harriet E Seward; Ker R Marshall; Hazel M Girvan; Myles R Cheesman; Michael R Waterman; Andrew W Munro
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

Review 10.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

View more
  43 in total

1.  Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Jialin Liu; W David Nes; Michael R Waterman; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

2.  Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.

Authors:  Jonathan B Johnston; Arti A Singh; Anaelle A Clary; Chiung-Kuan Chen; Patricia Y Hayes; Sharon Chow; James J De Voss; Paul R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

Review 3.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

4.  Comparative Study of GeneXpert MTB/RIF Assay and Multiplex PCR Assay for Direct Detection of Mycobacterium tuberculosis in Suspected Pulmonary Tuberculosis Patients.

Authors:  Anil Kumar Sah; Bishnu Joshi; Dhruba Kumar Khadka; Birendra Prasad Gupta; Anurag Adhikari; Subodh Kant Singh; Ganesh Rai; Geeta Shrestha Vaidya; Reema Rajbhandari; Basant Pant; Shiba Kumar Rai
Journal:  Curr Microbiol       Date:  2017-06-13       Impact factor: 2.188

5.  Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion.

Authors:  Santhosh Sivaramakrishnan; Hugues Ouellet; Hirotoshi Matsumura; Shenheng Guan; Pierre Moënne-Loccoz; Alma L Burlingame; Paul R Ortiz de Montellano
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

6.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

Review 7.  Updating and curating metabolic pathways of TB.

Authors:  Richard A Slayden; Mary Jackson; Jeremy Zucker; Melissa V Ramirez; Clinton C Dawson; Rebecca Crew; Nicole S Sampson; Suzanne T Thomas; Neema Jamshidi; Peter Sisk; Ron Caspi; Dean C Crick; Michael R McNeil; Martin S Pavelka; Michael Niederweis; Axel Siroy; Valentina Dona; Johnjoe McFadden; Helena Boshoff; Jocelyne M Lew
Journal:  Tuberculosis (Edinb)       Date:  2013-02-01       Impact factor: 3.131

8.  Deciphering the transcriptional regulation of cholesterol catabolic pathway in mycobacteria: identification of the inducer of KstR repressor.

Authors:  Esther García-Fernández; Francisco Javier Medrano; Beatriz Galán; José Luis García
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

9.  A highly conserved mycobacterial cholesterol catabolic pathway.

Authors:  Esther García-Fernández; Daniel J Frank; Beatriz Galán; Petrea M Kells; Larissa M Podust; José L García; Paul R Ortiz de Montellano
Journal:  Environ Microbiol       Date:  2013-03-14       Impact factor: 5.491

10.  Functional Characterization of Three Specific Acyl-Coenzyme A Synthetases Involved in Anaerobic Cholesterol Degradation in Sterolibacterium denitrificans Chol1S.

Authors:  Markus Warnke; Tobias Jung; Christian Jacoby; Michael Agne; Franziska Maria Feller; Bodo Philipp; Wolfgang Seiche; Bernhard Breit; Matthias Boll
Journal:  Appl Environ Microbiol       Date:  2018-03-19       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.